Objectives were to detennine 1) in vitro effects of bST on function of polymorphonuclear leukocytes and lymphocytes and 2} in vivo effects of bST on leukocyte function of heifers fed to maintain medium or high growth rates. When administered in vitro, bST did not affect function of polymorphonuclear leukocytes. [Methyl-3H]thymidine incorporation by resting lymphocytes was stimulated by 1000 ng/ml bST. When given in vitro, bST did not further enhance [methyl-3H]thymidine uptake by mitogen-stimulated lymphocytes cultured at 38SC but reduced the depression of mitogen-stimulated proliferation caused by incubating cells at 42"C. When bST was administered in vivo, phagocytosis and killing of Escherichia coli by polymorphonuclear leukocytes from bSTtreated heifers were not different from cells of control heifers. As measured by [methyl-3H]thymidine uptake after stimulation with phytohemagglutinin, lymphocytes from bST-treated heifers responded similarly to those of control heifers when incubated at 38.5"C, but the depression in [methyl-3H]thymidine uptake due to culture at 42-C was less for lymphocytes obtained from bST-treated
INTRODUCTION
Physiological levels of bST in lactating cows are between 1 and 6 ng/ml plasma, whereas subcutaneous daily injections of 30 mg bST increase average concentrations to 10 to 20 ng/ml (9) . Although the effect of bST on milk yields is indirect, i.e., probably in part mediated through insulin-like growth factors (6) , there is evidence for direct effects of s0-matotropin on cells of the inunune system in the bovine and in other species. For example, the administration of exogenous somatotropin alters the fimction of the immune system in somatotropin deficient and nondeficient animals. Depending on the physiological state and species, administration of exogenous s0-matotropin enhances (4. 5, 7, 10, 15, 21) , reduces (19, 20) . or has no effect (3, 8, 13) on the functional abilities of components of the immune system. Receptors for somatotropin have been identified on bovine and murine thymocytes (1) and on human lymphocytes (2, 11, 12, 14, 23) . Additionally, somatotropin production by rat and human lymphocytes has been reported (25). The objective of this study was to determine if bST alters the function of polymorphonuclear leukocytes (PMNL) and lymphocytes from heifers without somatotropin deficiency, when bST is given in vitro or in vivo.
MATERIALS AND METHODS

Reagents
Dulbecco's phosphate-buffered saline solution (DPBS), Dulbecco's modified Eagle's medium (DMEM), RPMI-l640, cytochrome c from horse heart (Type m and Vl), zymosan, Histopaque 1077, phytohemagglutinin (PHA), pokeweed mitogen (PWM), Concanavalin A (Con A), L-glutamine, and trypan blue were purchased from Sigma Chemical Co. (St. Louis, MO). The RPMI-l640 was supplemented (modified RPMI-l640) with 1% (voll vol) 200 roM L-glutamine, 100 IU/ml penicillin, 100 Ilg/ml streptomycin (OffiCO, Oaithersburg, MD), and 10% (voJ/vol) bovine calf serum (HyOone, Logan, UT). [Methyl-3H]thymidine (specific activity 5.0 Ci/mmol) was purchased from Amersham (Arlington Heights, IL). Agarose was purchased from OffiCO, brain-heart infusion broth from BBL Microbiology Systems (Becton Dickinson and Co., Cockeysville, MD) and modified Wright's stain (Leukostat) from Fisher Diagnostics (Orangeburg, NY). Sodium dodecyl sulfate was obtained from Hoefer Scientific Instruments (San Francisco, CA). A bovine serum pool was obtained from five Holstein cows. Recombinant bST for the in vitro experiment was lyophylized sometribove (methionyl bST) obtained from Monsanto Company (St. Louis, MO). When tested at 2 mg bST/kg body weight, this lot of bST (lot M-91-07226) was found to be free of pyrogenic activity using the rabbit pyrogen test (24) . For the in vivo experiment, bST (Met-Asp-Oln bST) was obtained from American Cyanamid Company (Princeton, NJ).
Animals and Experimental Design
In vitro experiments were performed on leukocytes isolated from peripheral blood leukocytes of lactating, primiparous Holstein cows. Effects of bST in vivo were tested by evaluating leukocyte function from 24 heifers Journal of Dairy Science Vol. 74, No.7, 1991 that, for other purposes, were assigned randomly to either medium or high growth rate groups. Heifers were group-fed com silage and grain concentrate to achieve growth rates of less (medium growth) or greater (high growth) than .9 kg/d from 4 to 12 mo of age. At 210 d of age, one-half of the heifers in each growth rate group were assigned to one of two bST treatments [daily subcutaneous injections of 1 ml saline (placebo) or bST (12.6 mg/d in saline)] for 112 d
Blood samples for the isolation of leukocytes for the investigation of components of the cellular immune system were collected between d 100 and d 112 of bST treatment by jugular venipuncture using evacuated heparinized blood collection tubes. Heifers were weighed biweekly. Three heifers from the placebo group were switched from the high growth rate group to the medium group because they gained less than .9 kg daily. Additionally, 1 heifer from the placebo group and 1 heifer from the bST group were shifted from the medium to the high growth rate group because their daily growth rate was greater than .9 kgld. Data were analyzed with 8 heifers in the medium growth with placebo group, 6 heifers in the medium growth with bST group, 4 heifers in the high growth with placebo group, and 6 heifers in the high growth with bST group. For lymphocyte proliferation only, observations were collected for 16 heifers.
Leukocyte Count and Differentiation
Blood (20 Ill) was diluted with 380 III of 3% [vollvol] formic acid to lyse red blood cells (RBC). Leukocytes in the resulting suspension were counted in a hemocytometer. For leukocyte differentiation, blood was spread on a microscopic slide and stained with modified Wright's stain. One hundred cells were differentiated under the oil immersion lens of a light microscope to determine relative numbers of neutrophilic and eosinophilic PMNL and mononuclear cells.
Isolation of Leukocytes
Blood (10 ml) was diluted 1:1 (vollvol) in DPBS, and the diluted blood was layered on 10 ml of Histopaque 1077 and centrifuged for 30 min at 400 x g. The packed RBC layer in the bottom, which contained the PMNL, was collected. The PMNL were separated from RBC by hypotonic lysis. For this procedure, 10 ml of distilled H20 were added to 5 to 10 ml of packed RBC and mixed. After 30 s, 10 ml double-strength DPBS were added to restore isotonicity. The cell suspension was centrifuged at 400 x g for 10 min, the supernatant was discarded, and the remaining RBC were lysed by repeating the procedure. The final PMNL pellet was resuspended at 10 7 live cells/ml (viability determined by nypan blue exclusion) in DPBS.
For the isolation of lymphocytes, cells in the interface between Histopaque 1077 and plasma were collected, suspended in 5 ml of DMEM, centrifuged for 10 min at 400 x g, and the cell pellet was resuspended in 4 ml of DMEM and layered on 4 ml of Histopaque 1(r77. After centrifugation for 30 min at 400 x g, the interface was collected, washed twice in 10 ml of DMEM with centrifugation at 400 x g for 10 min, and the cells were resuspended in modified RPMI-I640 at 1()6 live cells/ml (viability determined by trypan blue exclusion).
PMNL Functional Assays
Cytochrome c reduction was evaluated in a final volume of 1 ml of DPBS containing 80 mM cytochrome c and 20% [vol/vol] serum (18) by stimulating 3 x 1()6 PMNL with 4 mg of opsonized zymosan. Zymosan was opsonized by preincubation of 20 mglml of serum for 30 min at 38SC on a tube rotator. All reagents and cells were normalized to assay temperature before mixing. The reaction took place in test tubes incubated in a water bath at 38.5 or 42°C. The reaction was stopped at 5, 10, or 30 min after addition of opsonized zymosan by placing the test tubes on ice. Tubes then were centrifuged at 4°C for 10 min at 2600 x g, and absorbance of the supernatant was measured at 550 nm. The change in absorbance was calculated by subtracting values for control incubations maintained on ice during the incubation procedure. In the experiment on in vitro effects of bST on PMNL, cells from 4 lactating primiparous cows were preincubated for 1 h with 0, 10, 100, and 1000 ng bST/ml at 38.5 and 42°C. All tubes then were placed at 38SC for 10 min. Cytochrome c and zymosan were added, and incubation continued for 30 min at 38SC.
The assays of phagocytosis and killing of Escherichia coli by PMNL were modifications from other assays (17, 18) . A strain of E. coli obtained from a clinical case of mastitis was incubated overnight in brain-heart infusion broth at 38"C, centrifuged at 1000 x g, washed twice, and adjusted to lOS cfu/ml in DPBS (by spectrophotometric measurement of bacterial cell concentration at 620 om). For the assay, 40 J.11 of PMNL suspension were incubated with 20 J.11 of E. coli suspension and 40 J.1l of 25% (voVvol) serum pool in DPBS in roundbottomed microtiter plates (bacteria:PMNL 5: 1). After 2 h at 38.5 or 42"C on a plate rotator (plates at 75°C from horizontal), 20 J.11 of [methyl-3H]thymidine (.2 J.1Ci) in DPBS were added with 100 J.1l of either DPBS (phagocytosis assay) or .2% SDS in DPBS (killing assay). Plates were incubated for another 60 min at 38SC to allow incorporation of [methyl-3H]thymidine into DNA of noningested or surviving bacteria Controls with no E. coli (background, B) and with no PMNL (100% incorporation, 1) were incubated simultaneously. Bacteria were harvested onto glass fiber f'tlters using a semiautomatic cell harvester (MiniMash IT; Whittaker, Walkersville, MD). The incorporated radioactivity was determined by scintillation counting. For cells of each cow, test (T), B, and I were set up as quadruplicates and averaged for calculation of the phagocytosis index and killing index as 100 -100[(dpmT -dp1llB)/(dpmI -dp1llB)].
Migration of PMNL was evaluated under agarose (16) . Five milliliters of agarose 1% (wt/vol), containing 5% (voVvol) bovine calf serum in DPBS were poured into a 6-cm diameter plastic Petri dish. Rows of three wells of 5-mm diameter were cut 3 mm apart into the approximately 2-mm thick agarose layer. A suspension of 25 J.1l of PMNL were pipetted into the central well of each row. Either 25 J.11 of DPBS (random migration) or 25 J.1l of activated serum obtained as supernatant from the opsonization of zymosan (total migration) were placed in the other wells. Dishes were incubated in 5% CO 2 for 2 h, and migration was stopped by placing plates at 4"C. Plates were inverted on the microscope and unfixed and unstained cells were examined through the bottom of the plate. Average distance migrated by the 100 cells most distant from the center well was measured using a lOx 100mm graticule in the ocular and the 40x magnification lens from a light microscope. One graticule unit corresponded to 25.5 JU11.
Results were averaged for triplicate determinations per sample. Chemotaxis was calculated as the difference in distance between total migration and random migration.
Lymphocyte Proliferation Assay
One hWldred microliters of lymphocyte suspension were placed into flat-bottomed test wells of a sterile 96-well microtiter plate, followed by various doses of PHA, PWM. or Con A in a total volume of 150 J11 of modified RPMI-l640 per wen. After 48 h of culture in a 5% C~and humid environment at 38.5 or 42"C, 50 J11 of [methyl-3H]thymidine (.1 J1Ci/ well) in modified RPMI-l640 were added to each well. In separate wells for estimation of viability, 50~of modified RPMI-l640 without [methyl-H]thymidine were added. Cells were harvested onto glass fiber fIlters 12 h later and washed with deionized water using the semiautomatic cell harvester. Radioactivity incorporated into newly synthesized DNA was determined by scintillation counting. All determinations were performed in triplicate. Viabilities were determined without replication.
In the experiment to study in vitro effects of bST on lymphocytes, cells from 3 lactating primiparous cows were cultured for 60 h at 38.5 or 42"C with no mitogen, .5 J1g PHN well, 2 J1g PWM/well, or 2 J1g Con NweU and with 0, 10, 100, and 1000 ng bST/ml. [Methyl-3H]thymidine uptake was evaluated during the last 12 h of culture. To test effects of bST in vivo, lymphocytes isolated from 16 heifers treated with bST or placebo were incubated for a total of 60 h at 38.5 or 42"C after stimulation with 0, .05, .1, and .2 J1g PHA/weU.
Statistical Analysis
Data management and analysis were performed using the general linear models procedure of the SAS (22) . Least squares analysis of variance models for in vitro experiments included cow, bST, incubation temperature, and their interactions. All effects were considered fIxed.
For the in vivo experiment, least squares analysis of variance model was performed for loumal of Dairy Science Vol. 74, No.7, 1991 a 2 x 2 factorial model. Growth rate and bST treatment were in the main plot, and incubation temperature and dose of mitogen were in the subplots of a split-plot design. Effects in the main plot were tested with heifer nested in growth rate x bST. All effects were considered fixed except for heifer, which was considered a random effect
RESULTS
In Vitro Effects of bST on PMNL
Viability of cells was not affected by concentration of bST (results not shown) but was higher at 38.5 than at 42"C (92.4 vs. 90.7%, SEM =.3, P < .05). Reduction of cytochrome c was less for PMNL preincubated at 42"C than for PMNL preincubated at 38SC (absorbance at 550 om: .506 vs. .434, SEM = .011, P < .01). Preincubation with bST did not affect subsequent cytochrome c reduction, and no preincubation temperature x bST dose interaction was detected.
In Vitro Effects of bST on Lymphocytes
After incubation for 60 h, viability of cells was not affected by bST but was lower for lymphocytes incubated at 42"C (PHA: 70.3 vs.
52.8%, SEM = 1.2%, P < .05; Con A: 79.9 vs. Proliferation of lymphocytes was depressed by high temperature incubation at 42"C in nonstimulated and aU mitogen-stimulated cultures at aU concentrations of bST (Figures 1   and 2 ). When cells were cultured without mitogen, incorporation of [methyl-3H]thymidine increased with increasing concentrations of bST (P < .01; Figure 1 ). In particular, bST had mitogenic effects at 1000 ng/ml (contrast 0, 10, and 100 ng/ml vs. 1000 ng bST/ml; P < .01). Treatment with bST had no effect on mitogen-stimulated lymphocytes at 38.5 and 42"C ( Figure 2 ). Data in Figure 3 are presented to show the effect of bST on the percentage inhibition of thymidine incorporation caused by culture at 42"C. There was no effect of bST on inhibition of thymidine incorporation
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bST (ng/ml) Figure 1 . Incorporation of [methyl-3Hlthymidine by lymphocytes in the presence of 0, 10, 100, or 1000 ng bST/ml and incubated without mitogen at 38.5'C (0) and 42"C (e). Incorporation of [methyl-Jmthymidine was depressed at all bST colICentrations by incubation at 42"C (P < .01). Incorporation of [methyl-~thymidine increased with increasing cOlICeotrations of bST (P < .01).
caused by elevated temperature for cells incubated without mitogen or with PHA. However, the inhibition of incorporation due to elevated temperature decreased with increasing concentrations of bST for cells stimulated with PWM (P < .05) and Con A (P < .05; Figure 3 ).
In Vivo Effects and Growth Rate on White Blood Cell Counts
The total number of leukocytes (P = .06) and mononuclear cells (P < .05) were lower in heifers treated with bST. The number of eosinophils (P = .09) tended to be higher for heifers with high growth rate than for heifers with medium growth rate ( Table 1) .
In Vivo Effects and Growth Rate on PMNL Function In Vitro
Cytochrome c reduction was reduced for cells incubated at 42"C (absOIbance at 550 nm:
.595 vs. .471; SEM =.009, P < .01) for heifers in all treatment groups. No effects of growth rate, bST, or any interactions on cytochrome c reduction were measured (Table 2) . ...... a,~eans within a column with different superscripts differ at P < .10.
e,dMeans within a column with different superscripts differ at P < .05.
to be improved in the high growth rate heifers, but bST had no effects on phagocytosis or killing ( Table 2) . High incubation temperature reduced random migration (72.3 vs. 42.4, SEM = 6.4 JUIl, P < .01) but did not alter chemotaxis (results not shown). Random migration and chemotaxis were not affected by growth rate or by bST (Table 2 ).
In Vivo Effects and Growth Rate on Lymphocyte Proliferation In Vitro
Incorporation of [methyPH]thymidine by lymphocytes increased with concentration of PHA (P < .01) and was reduced at high incubation temperature (P < .01; Figure 4 ). Elevated temperature caused a greater inhibition of [methyPH]thymidine incorporation at lower concentrations of PHA (concentration of PHA x incubation temperature; P < .01). Depression of incorporation of [methyl-3H]thymidine by elevated temperature was less for lymphocytes collected from bST-treated heifers than for lymphocytes collected from heifers treated with placebo (dose of PHA x incubation temperature x bST treatment; P = .05). These interactions were also apparent when the percentage inhibition of incorporation due to elevated temperature was calculated for each heifer as 100(1-(dpm at 42"C/dpm at 38.S"C».
The inhibition of [methyl-3H]thymidine incorporation caused by culture at elevated temperature decreased from 85.5 ± 1.5% at .05 J.1g PHA/well to 65.2 ± 1.5% at . cells cultured without other mitogens. This effect was unlikely due to endotoxin contamination of the bST because the bST preparation used was nonpyrogenic in the rabbit pyrogen test. Whether the mitogenic effect of bST is of physiological imponance is not known. Concentrations that were mitogenic were much greater than those found in blood of dairy cows, even when cows were treated with bST. Somatotropin has been reported to be synthesized and released by lymphocytes (25), and it is possible that local concentrations of bST may be high enough in cenain lymphoid tissues to be mitogenic. In the presence of other mitogens, bST did not increase [methyl-3H]thymidine uptake at 38SC but did reduce the inhibition of incorporation in cells stimulated with PWM and PHA caused by culture at 42°C. As found by others (8) , administration of bST in vivo did not alter lymphocyte proliferation after PHA stimulation in culture. In contrast, one repon (4) indicated that lymphocytes isolated from bST-treated cows had enhanced responsiveness to stimulation with Con A In the present study, lymphocytes stimulated with PHA from heifers treated with bST were less sensitive to the inhibiting effects of culture at 42°C. Thus, administration of bST in vivo conferred upon lymphocytes a degree of tolerance to elevated temperature in vitro.
No effects on PMNL function in vitro or in vivo were detected in these studies. Other investigators reported that bST treatment in vivo increased oxidative metabolism by PMNL from lactating cows 5 to 8 d after initiation of treatment (10) , whereas phagocytosis of Staphylococcus aureus was not affected (8) . Differences in effects of bST on oxidative metabolism may have resulted because of differences in the animals used (growing heifer versus lactating cow) and duration of bST treatment (100 to 112 d vs. 5 to 8 d).
In summary, bST did not affect PMNL function while having mitogenic and thermoprotective effects on lymphocytes. The physiological significance and mechanisms involved in these effects are unknown but deserve funher attention.
